Keyphrases
Melanoma
83%
Metastatic Melanoma
38%
Photoacoustic Microscopy
21%
Skin Cancer
19%
Handheld
19%
Pooled Analysis
19%
Melanocortin 1 Receptor (MC1R)
17%
Matrix Metalloproteinases
15%
Melanoma Patients
14%
Calcipotriol
13%
Endothelial Cells
13%
Immune Checkpoint Inhibitors
12%
Vemurafenib
12%
Rap1
11%
Microvasculature
11%
Human Dermal Microvascular Endothelial Cells (HDMECs)
11%
Tumorigenesis
11%
Melanoma Treatment
11%
Melanoma Cells
10%
Head-and-neck
10%
MMP-12
10%
Neutrophil Elastase
10%
Itch
9%
Merkel Cell Carcinoma
9%
Cell Survival
9%
Photoacoustic Probe
9%
Intercellular Adhesion molecule-1 (ICAM-1)
9%
Cancer Precursor
9%
Gene Variants
9%
Human Skin
9%
Ultraviolet-B (UV-B)
9%
5-fluorouracil (5-FU)
8%
Phenotypic Characteristics
8%
Metastasis
8%
Linear Array
8%
Squamous Cell Carcinoma (SqCC)
8%
Pembrolizumab
7%
Melanoma Imaging
7%
Tumor Growth
7%
Tumor Depth
7%
Tumor
7%
Molecular Mechanism
7%
Genetic Factors
7%
Occlusion
7%
Ipilimumab
7%
Melanoma Risk
7%
Vascular Endothelial Cells
6%
Cell Migration
6%
Melanocytic Tumor
6%
Actinic Keratosis
6%
Medicine and Dentistry
Melanoma
100%
Photoacoustic Microscopy
24%
Melanoma Skin Cancer
20%
Immunotherapy
19%
Calcipotriol
19%
Neoplasm
18%
Diseases
17%
Endothelial Cell
16%
Metastatic Melanoma
16%
Skin Cancer
14%
Pooled Analysis
14%
Fluorouracil
14%
Metastatic Carcinoma
13%
Malignant Neoplasm
13%
Microvessel
11%
Squamous Cell Carcinoma
10%
Nevus
10%
Pruritus
10%
Matrix Metalloproteinase
10%
Systematic Review
9%
Melanocortin 1 Receptor
9%
Downregulation
9%
Receptor Gene
9%
Precursor
9%
Neck
9%
Carcinogenesis
9%
Immune Checkpoint Inhibitor
8%
Cancer
8%
Mitogen-Activated Protein Kinase
8%
Scalp
8%
Odds Ratio
8%
Pembrolizumab
7%
Tumor Progression
7%
Cell Proliferation
7%
Vemurafenib
7%
Integrin
7%
Programmed Cell Death
6%
Cell Migration
6%
Dermatosis
6%
Melanocyte
6%
Cell Signaling Pathway
6%
Surgery
6%
Clinical Trial
6%
Macrophage Elastase
5%
Fibroblast Growth Factor 2
5%
Interferon
5%
Tumor Cell
5%
Volunteer
5%
Cardiovascular System
5%
Melanoma Cell
5%